As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

A new study found bariatric ... and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

Eli Lilly's Mounjaro joins list of obesity and diabetes drugs made popular by celebrities who lost weight The latest ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of Ozempic. This new drug stimulates calorie burning and reduces appetite ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

The new weight-loss drugs have created ... an early-generation GLP-1 drug—cut BMI by at least 5 percent in most participants after 56 weeks. A 2022 trial of 201 teens aged 12 to 18 reported ...

Others quit because they achieved their weight loss goals — though it’s common to regain weight when you cease taking the drugs. The study authors plan to start clinical trials within the next ...

New research shows a marked decline in weight-loss surgeries as GLP-1 meds like Wegovy or Zepbound surge in popularity Bariatric surgeries fell by more than a quarter between 2022 and 2023, as ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...